Report Detail
Global (United States, European Union and China) Cancer Biomarker Market Research Report 2019-2025
- RnM3691782 |
- 23 August, 2019 |
- Global |
- 121 Pages |
- QYResearch |
- Pharma & Healthcare
Cancer biomarkers are substances or processes that are indicative of the presence of cancers in the human body. Biomarkers may be produced by the cancer tissue itself or by other cells in the body in response to cancer. They can be found in the blood, stool, urine, tumor tissue, or other tissues or bodily fluids.
In terms of applications, diagnostics accounted for major share of the global cancer biomarkers market in 2017.
In 2019, the market size of Cancer Biomarker is 11600 million US$ and it will reach 29300 million US$ in 2025, growing at a CAGR of 12.3% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Cancer Biomarker.
This report studies the global market size of Cancer Biomarker, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Cancer Biomarker sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Thermo Fisher Scientific
Bio-Rad Laboratories
Roche Diagnostics
Qiagen
Illumina
GE Healthcare
Agilent Technologies
Biomérieux SA
Merck & Co.
Abbott Laboratories
Becton, Dickinson and Company
Danaher Corporation
Myriad Genetics
Sysmex Corporation
Hologic
Quest Diagnostics
Market Segment by Product Type
Protein Biomarker
Genetic Biomarker
Market Segment by Application
Diagnostics
Research
Prognostics
Risk Assessment
Other Applications
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Cancer Biomarker status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Cancer Biomarker manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Cancer Biomarker are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Cancer Biomarker Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Protein Biomarker
- 1.3.3 Genetic Biomarker
- 1.4 Market Segment by Application
- 1.4.1 Global Cancer Biomarker Market Share by Application (2019-2025)
- 1.4.2 Diagnostics
- 1.4.3 Research
- 1.4.4 Prognostics
- 1.4.5 Risk Assessment
- 1.4.6 Other Applications
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Cancer Biomarker Market Size
- 2.1.1 Global Cancer Biomarker Revenue 2014-2025
- 2.1.2 Global Cancer Biomarker Sales 2014-2025
- 2.2 Cancer Biomarker Growth Rate by Regions
- 2.2.1 Global Cancer Biomarker Sales by Regions 2014-2019
- 2.2.2 Global Cancer Biomarker Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Cancer Biomarker Sales by Manufacturers
- 3.1.1 Cancer Biomarker Sales by Manufacturers 2014-2019
- 3.1.2 Cancer Biomarker Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Cancer Biomarker Revenue by Manufacturers (2014-2019)
- 3.2.2 Cancer Biomarker Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Cancer Biomarker Market Concentration Ratio (CR5 and HHI)
- 3.3 Cancer Biomarker Price by Manufacturers
- 3.4 Key Manufacturers Cancer Biomarker Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Cancer Biomarker Market
- 3.6 Key Manufacturers Cancer Biomarker Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Protein Biomarker Sales and Revenue (2014-2019)
- 4.1.2 Genetic Biomarker Sales and Revenue (2014-2019)
- 4.2 Global Cancer Biomarker Sales Market Share by Type
- 4.3 Global Cancer Biomarker Revenue Market Share by Type
- 4.4 Cancer Biomarker Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Cancer Biomarker Sales by Application
6 United States
- 6.1 United States Cancer Biomarker Breakdown Data by Company
- 6.2 United States Cancer Biomarker Breakdown Data by Type
- 6.3 United States Cancer Biomarker Breakdown Data by Application
7 European Union
- 7.1 European Union Cancer Biomarker Breakdown Data by Company
- 7.2 European Union Cancer Biomarker Breakdown Data by Type
- 7.3 European Union Cancer Biomarker Breakdown Data by Application
8 China
- 8.1 China Cancer Biomarker Breakdown Data by Company
- 8.2 China Cancer Biomarker Breakdown Data by Type
- 8.3 China Cancer Biomarker Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Cancer Biomarker Breakdown Data by Company
- 9.2 Rest of World Cancer Biomarker Breakdown Data by Type
- 9.3 Rest of World Cancer Biomarker Breakdown Data by Application
- 9.4 Rest of World Cancer Biomarker Breakdown Data by Countries
- 9.4.1 Rest of World Cancer Biomarker Sales by Countries
- 9.4.2 Rest of World Cancer Biomarker Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Thermo Fisher Scientific
- 10.1.1 Thermo Fisher Scientific Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Cancer Biomarker
- 10.1.4 Cancer Biomarker Product Introduction
- 10.1.5 Thermo Fisher Scientific Recent Development
- 10.2 Bio-Rad Laboratories
- 10.2.1 Bio-Rad Laboratories Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Cancer Biomarker
- 10.2.4 Cancer Biomarker Product Introduction
- 10.2.5 Bio-Rad Laboratories Recent Development
- 10.3 Roche Diagnostics
- 10.3.1 Roche Diagnostics Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Cancer Biomarker
- 10.3.4 Cancer Biomarker Product Introduction
- 10.3.5 Roche Diagnostics Recent Development
- 10.4 Qiagen
- 10.4.1 Qiagen Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Cancer Biomarker
- 10.4.4 Cancer Biomarker Product Introduction
- 10.4.5 Qiagen Recent Development
- 10.5 Illumina
- 10.5.1 Illumina Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Cancer Biomarker
- 10.5.4 Cancer Biomarker Product Introduction
- 10.5.5 Illumina Recent Development
- 10.6 GE Healthcare
- 10.6.1 GE Healthcare Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Cancer Biomarker
- 10.6.4 Cancer Biomarker Product Introduction
- 10.6.5 GE Healthcare Recent Development
- 10.7 Agilent Technologies
- 10.7.1 Agilent Technologies Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Cancer Biomarker
- 10.7.4 Cancer Biomarker Product Introduction
- 10.7.5 Agilent Technologies Recent Development
- 10.8 Biomérieux SA
- 10.8.1 Biomérieux SA Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Cancer Biomarker
- 10.8.4 Cancer Biomarker Product Introduction
- 10.8.5 Biomérieux SA Recent Development
- 10.9 Merck & Co.
- 10.9.1 Merck & Co. Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Cancer Biomarker
- 10.9.4 Cancer Biomarker Product Introduction
- 10.9.5 Merck & Co. Recent Development
- 10.10 Abbott Laboratories
- 10.10.1 Abbott Laboratories Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Cancer Biomarker
- 10.10.4 Cancer Biomarker Product Introduction
- 10.10.5 Abbott Laboratories Recent Development
- 10.11 Becton, Dickinson and Company
- 10.12 Danaher Corporation
- 10.13 Myriad Genetics
- 10.14 Sysmex Corporation
- 10.15 Hologic
- 10.16 Quest Diagnostics
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Cancer Biomarker Sales Channels
- 11.2.2 Cancer Biomarker Distributors
- 11.3 Cancer Biomarker Customers
12 Market Forecast
- 12.1 Global Cancer Biomarker Sales and Revenue Forecast 2019-2025
- 12.2 Global Cancer Biomarker Sales Forecast by Type
- 12.3 Global Cancer Biomarker Sales Forecast by Application
- 12.4 Cancer Biomarker Forecast by Regions
- 12.4.1 Global Cancer Biomarker Sales Forecast by Regions 2019-2025
- 12.4.2 Global Cancer Biomarker Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Cancer Biomarker. Industry analysis & Market Report on Cancer Biomarker is a syndicated market report, published as Global (United States, European Union and China) Cancer Biomarker Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Cancer Biomarker market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
